Recent study has demonstrated that Bcl-2 is overexpressed in ovarian cancer [30, 31] and has a significant positive correlation with sensitivity to cisplatin in ovarian cancer cells [32]. The gene discussed is BCL2; the disease is ovarian carcinoma.